Antiplatelet agents'-ticagrelol and eptifibatide-safety in experimental colitis in mice.

CONCLUSION: The antiplatelet agents ticagrelor and eptifibatide were safe in DSS colitis mice, suggesting their potential in humans suffering from ulcerative colitis, and supporting future safety studies.
PMID: 32721916 [PubMed - in process]

Source: The Turkish Journal of Gastroenterology - May 31, 2020 Category: Gastroenterology Authors: Petrovic SS, Vasiljevska MM, Obradovic SD, Tarabar DK, Doder RB, Majstorovic IJ, Petrovic MD, Magic ZM, Cikota BM, Perisic NJ, Brcerevic IA, Manojlovic NS, Rancic NK Tags: Turk J Gastroenterol Source Type: research